Amgen Italia is a subsidiary of Amgen Inc., a leading global biotechnology company specializing in the development and commercialization of innovative human therapeutics. The company focuses on areas such as oncology, cardiovascular disease, and inflammation, leveraging advanced biotechnological methods to create life-changing medicines. Amgen generates revenue through the sale of its pharmaceutical products and invests heavily in research and development to maintain a robust pipeline of new treatments. Established in 1980, Amgen has a rich history of scientific breakthroughs and a strong commitment to improving patient outcomes worldwide.